EXPERT PERSPECTIVES IN ATOPIC DERMATITIS

Experts in the field discuss new therapies and how they will impact the dermatologist's practice.

Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis

Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis.

MORE EXPERT PERSPECTIVES IN ATOPIC DERMATITIS